Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Callisto Pharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Callisto Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Callisto Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is KAL. The reporting company's CIK number is 1142380.
The total value of stock buying since 2005 is $154,021.
The total value of stock sales since 2005 is $23,150.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-11-15||Cerrone Gabriel (Director)||Buy||12,935||.00||0|
|2010-01-19||Bruening Christoph (Director)||Sale||15,000||.23||3,480|
|2010-01-13||Bruening Christoph (Director)||Sale||5,000||.24||1,225|
|2010-01-11||Bruening Christoph (Director)||Sale||25,000||.24||6,125|
|2010-01-08||Bruening Christoph (Director)||Sale||55,000||.22||12,320|
|2006-08-21||Jacob Gary S (Chief Executive Officer)||Buy||5,000||.84||4,200|
|2005-06-16||Jacob Gary S (Chief Executive Officer)||Buy||5,000||1.00||5,000|
|2005-06-09||Cerrone Gabriel (Chairman)||Buy||5,000||1.00||5,000|
|2005-06-03||Cerrone Gabriel (Chairman)||Buy||6,000||1.02||6,120|
|2005-05-27||Cerrone Gabriel (Chairman)||Buy||8,000||1.00||7,976|
|2005-05-19||Cerrone Gabriel (Chairman)||Buy||12,500||1.02||12,750|
|2005-04-15||Bruening Christoph (Director)||Buy||15,000||1.30||19,575|
|2005-03-09||Jacob Gary S (Chief Executive Officer)||Buy||16,448||1.52||25,000|
|2005-03-09||Cerrone Gabriel (Chairman)||Buy||25,000||1.52||38,000|
|2005-03-09||Bruening Christoph (Director)||Buy||20,000||1.52||30,400|
Insider trading activities including stock purchases, stock sales, and option exercises of KAL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Callisto Pharmaceuticals Inc (symbol KAL, CIK number 1142380) see the Securities and Exchange Commission (SEC) website.